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Abstract Since the infusion of P1,P4-diadenosine 5P tetra-
phosphate (Ap4A) into animal models induces vasodilation [1,2],
the present study was performed to determine whether Ap4A
induces the release of nitric oxide (NO) from endothelial cells.
Ap4A induced NO release was 4.2-fold greater than the amount
of NO released under basal condition. Ap4A induced NO release
was inhibited by NG-nitro-L-arginine (L-NNA) and this inhibi-
tion was reversed by L-Arg. In addition, EGTA inhibits Ap4A
induced NO release. These data are consistent with Ap4A
inducing the release of NO from endothelial cells through the
activation of endothelial nitric oxide synthase.
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1. Introduction
Adenine dinucleotides are attracting considerable interest
because of increasing evidence that they act as extracellular
modulators. Adenine dinucleotides consists of K,g-adenine
dinucleotides which consist of two adenosine moieties linked
via their 5P positions by a chain of 2 to 6 phosphates (ApxA,
where x represents the number of phosphates in the connect-
ing chain). The K,g-adenine dinucleotides are present in a
diverse number of biological tissues including platelets, hep-
atocytes, adrenal medullary chroma⁄n granules and the cen-
tral nervous system [3^7].
P1,P4-diadenosine 5P tetraphosphate (Ap4A) is one of the
most abundant and best characterized of the adenine dinu-
cleotides. Ap4A, Ap3A, Ap5A, Ap6A and ATP are co-stored
in dense secretory granules of platelets, and upon platelet
aggregation, are released into the extracellular milieu follow-
ing stress [4,5,8,9]. In chroma⁄n cells, Ap4A, Ap5A and
Ap6A are co-stored with AMP, ADP, ATP and catechol-
amines [10]. It has been estimated that following localized
release from platelets or chroma⁄n cells Ap4A could reach
physiologically signi¢cant concentrations. Furthermore, com-
pared with ATP, Ap4A has a relatively long half-life in whole
blood [11]. Thus, Ap4A is well suited for a role as an extra-
cellular modulator.
Our laboratory has demonstrated the presence of mem-
brane receptors for Ap4A in brain, liver, kidney, cardiac,
spleen and adipose tissue [12]. The presence of the receptor
in a diversity of tissue types and localization of the Ap4A
receptor on the cell surface [13] supports the notion that cir-
culating Ap4A is a modulator of cellular functions. Indeed
extracellular Ap4A has been shown to modulate blood vessel
tone [1,2,14], inhibit platelet aggregation [9], prime respiratory
burst [15], regulate apoptosis in neutrophils [15], induce cat-
echolamine release from chroma⁄n cells [16] and activate gly-
cogen phosphorylase in hepatocytes [17].
The notion that circulating Ap4A may be involved as an
extracellular modulator led us to focus our e¡orts on de¢ning
a physiological role for Ap4A. As a step in this direction we
have demonstrated that the infusion of Ap4A into the precava
of swine triggers a dose dependent decrease in the mean arte-
rial blood pressure without a¡ecting the heart rate or right
ventricular pressure [1]. Similar activity was noted when Ap4A
was infused into the femoral vein of dogs [2]. Other investi-
gators have demonstrated that the infusion of Ap4A through
isolated rabbit hearts also induces vasodilation [18]. In this
communication we present evidence that demonstrates Ap4A
induces bovine aortic endothelial cells (BAEC) to release ni-
tric oxide (NO) and that Ap4A induces the release of 4.2-fold
more NO over basal levels. Since NO is the major physiolog-
ical regulator of basal blood vessel tone [19,20] these data are
consistent with Ap4A exerting its vasodilation a¡ect by induc-
ing endothelial cells to release NO.
2. Materials and methods
2.1. Materials
BAEC were kindly supplied by Dr. Robert Auerbach of the Uni-
versity of Wisconsin. Minimal essential medium (MEM), penicillin
and streptomycin were purchased from GIBCO. Heat inactivated fetal
bovine calf serum (FSB) was purchased from HyClone. Nitrate stand-
ard solution was purchased from EM Science. NG-nitro-L-arginine
(L-NNA) was purchased from Calbiochem. NG-methyl-L-arginine
(L-NMA) was purchased from ICN Biochemicals. Arginine, super-
oxide dismutase derived from bovine liver and all nucleotides were
purchased from Sigma. All other reagents were of analytical reagent
grade or better.
2.2. Cell culture
2U105 BAEC were seeded in 35 mm gelatin-coated petri dishes
and grown in medium, pH 7.4, consisting of MEM, 10% (v/v) FBS,
0.044 mol/l of NaHCO3, penicillin (100 units/ml) and streptomycin
(100 Wg/ml). Cell cultures were maintained at 37‡C in a humidi¢ed
atmosphere of 95% air-5% Co2. All experiments were performed with
passage 6 through 10 cells.
2.3. Calibration of the electrode
NO was measured using the ISO-NO Mark II Isolated Nitric Oxide
Meter using and ISO-NOP Sensor (World Precision Instruments, Inc.,
Sarasota, FL). The principle of measurement and the electrode design
have been previously described [21,22]. Calibration of the electrode
was performed by titration as described [23]. The titration method
always detected NO standards with good linearity (r = 0.99 to 1.0)
but the sensitivity showed variations between 0.85 and 3.23 nM
NO/pA. Therefore calibration of the NO electrode was performed
on each day.
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2.4. NO measurements
BAEC grown 35 mm gelatin-coated petri dishes were washed three
times with Krebs-Henseleit bu¡er (0.01 mol/l HEPES (pH 7.4), 0.12
mol/l NaCl, 0.0046 mol/l KCl, 0.0015 mol/l CaCl2, 0.0005 mol/l
MgCl2, 0.0015 mol/l NaH2PO4, 0.007 mol/l Na2HPO4, 0.01 mol/l
glucose), resuspended in 2.0 ml of Krebs-Henseleit bu¡er and incu-
bated for 60 min at 37‡C in a humidi¢ed atmosphere of 95% air-5%
CO2. The cells were then washed three times with Krebs-Henseleit
bu¡er (pH 7.1) prior to the addition of 2.0 ml of Krebs-Henseleit
bu¡er (pH 7.1) containing 10 U/ml of superoxide dismutase. For
experiments the sensor probe was inserted vertically into the petri
dish containing BAEC so that the tip of the probe was about 1 mm
into the solution. The dishes were not capped and all measurements
were performed at room temperature. The data were collected and
analyzed using the DUO 18 2 Channel, 18-Bit Data Recording System
(World Precision Instruments, Inc., Sarasota, FL). Data were col-
lected for 60 min (5 samples/s). The total nmoles of NO were deter-
mined after 60 min of incubation. Signal to background ratio was 475
( þ 50).
2.5. Determination of cell number
After each experiment the total number of cells in the petri dishes
were determined by washing the dishes with 1 ml of phosphate bu¡-
ered saline pH 7.4 (PBS) followed by incubating the cells with 1 ml of
trypsin (1.25 Wg/ml) and 1 mM EDTA at room temperature until the
cells were released. Trypsin was inactivated by diluting the cells into
2 ml of trypsin inhibitor (1 mg/ml). Cell densities were determined by
counting in a hemocytometer. Each sample was counted eight times.
2.6. Measurement of nucleotide degradation by BAEC
BAEC grown 35 mm gelatin-coated petri dishes were washed three
times with Krebs-Henseleit bu¡er incubated at room temperature with
either 6 WM Ap4A (1U106 cpms/pmole) or 6 WM ATP (1U106 cpms/
pmole) in a ¢nal volume of 0.1 ml of Krebs-Henseleit bu¡er. After
incubation 2 Wl aliquots, along with standards (Ap4A, ATP, ADP,
AMP and [32P]-inorganic phosphate) were spotted on DC-Plastikfo-
lien PEI-Cellulose F plates (TLC plates). The plates were developed
using 1 M LiCl2 as described [24]. After development, the plates were
dried and autoradiography was carried out at room temperature for
6 h using Kodak X-OMATAR X-ray ¢lm and Cronex Lighting Plus
intensifying screens.
Densitometer tracings of autoradiographs were obtained using a
Pharamcia LKB UltraScan XL Enhanced Laser Densitometer con-
nected to an IBM 486 Personal Computer with LKB GelScan XL
(version 2.1) software.
3. Results
3.1. E¡ect of con£uence on Ap4A induced NO release
To determine the e¡ect of Ap4A on BAEC we measured the
amount of NO released at di¡erent days of cell growth in
response to Ap4A (Fig. 1). Con£uence was determined by
visual inspection of the cells and deemed present when more
than 95% of the cells were in contact with adjacent cells [25].
Under the culture conditions used in this communication the
cells reached con£uence 5 days after subculturing. Even after
reaching con£uence the cell number continued to increase
while the cells decreased in size and became tightly packed
before plateauing at day 8 (Fig. 1A). Both basal and Ap4A
stimulated release of NO was at least 3-fold greater in cells in
early growth phase (days 3^6) as compared to cells at plateau
(days 8^10). Cell viability of day 3^8 cells was greater than
95% as shown by trypan blue exclusion (data not shown).
Furthermore day 3^8 cells released less than 5% of lactate
dehydrogenase found in total lysates (data not shown). These
data are consistent with other investigators who have demon-
strated that the expression of endothelial cell NO synthase
(eNOS) is increased in proliferating as compared to quiescent
cells [25]. All subsequent experiments were performed using
day 4 to 6 cells.
3.2. E¡ect of adenine dinucleotides on NO release
The ability of ATP and various adenylated dinucleotides to
induce the release of NO from BAEC was compared (Fig. 2
and Table 1). Basal, Ap4A, Ap2A, Ap3A, Ap5A, Ap6A and
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Fig. 1. E¡ect of BAEC cell growth on the release of NO after in-
duction with Ap4A. A: 2U105 BAEC were seeded in 35 mm gela-
tin-coated petri dishes and grown as described in Section 2. At the
days indicated the cells were released from the dishes by trypsin di-
gestion and counted in a hemocytometer as described in Section 2.
B: 2U105 BAEC were seeded in 35 mm gelatin-coated petri dishes,
grown and prepared as described in Section 2. At the indicated
days the BAEC were washed and prepared as described in Section 2
prior to adding 1 WM Ap4A. NO released was recorded and ana-
lyzed as described in Section 2. Ap4A induced release of NO (F) ;
basal release of NO (E). Data are averages of four di¡erent experi-
ments. Error bars are shown as standard deviations.
Table 1
E¡ect of adenylated dinucleotides on NO release from BAEC
Adenylated dinucleotide cells nmoles/min/106
Ap4A 0.83 þ 0.044
Ap2A 0.66 þ 0.035
ATP 0.39 þ 0.027
Basal 0.20 þ 0.021
Ap6A 0.25 þ 0.025
Ap5A 0.23 þ 0.026
Ap3A 0.17 þ 0.024
2U105 BAEC were seeded in 35 mm gelatin-coated petri dishes,
grown and prepared as described in Section 2 prior to adding 6 WM
to the indicated dinucleotide. NO release was recorded and analyzed
as described in Section 2. Data are averages of four di¡erent experi-
ments and reported as standard deviations.
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ATP stimulated release of NO from BAEC increased with
incubation time (Fig. 2). After 60 min of incubation, basal
release was about 13 nmoles/106 cells ; this release of NO
increased 3.8-, 3.0- and 1.8-fold in response to 6 WM Ap4A,
Ap2A and ATP, respectively (Fig. 2A and Table 1). On the
other hand Ap3A, Ap5A and Ap6A did not induce NO release
above basal levels (Fig. 2B and Table 1). These data are con-
sistent with Ap4A, Ap2A and ATP stimulating the release of
NO from BAEC.
3.3. Nucleotide hydrolysis by BAEC
To ensure that Ap4A is not hydrolyzed by BAEC during
NO assays, 6 WM [32P]-Ap4A was incubated for various times
at room temperature with BAEC suspended in 0.1 ml of
Krebs-Henseleit bu¡er (pH 7.1). Aliquots were subjected to
thin layer chromatography [24] followed by autoradiography.
After 60 min of incubation 90% of the radiolabeled Ap4A co-
migrates with nonradiolabeled Ap4A while ATP was rapidly
degraded (Fig. 3). We estimated that 50% of the radiolabeled
ATP was degraded between 3 to 4 min and after 60 min there
was essentially no radiolabeled material co-migrating with
ATP. These data are consistent with Ap4A inducing the re-
lease of NO from BAEC. Due to the rapid hydrolysis of ATP
we can not determine whether the release of NO in the pres-
ence of 6 WM ATP is due to ATP or its degradative products.
3.4. E¡ects of arginine antagonists on Ap4A induced release
of NO
Since L-Arg is the biosynthetic precursor of eNOS [26] and
NG-methyl-L-arginine (L-NMA) and NG-nitro-L-arginine (L-
NNA) are competitive inhibitors of eNOS [27] the e¡ect of
these analogs on Ap4A induced NO release was determined.
As shown in Fig. 4A both of these analogs inhibit the release
of NO in a dose dependent fashion. We estimate that 50% of
NO release is inhibited at 10 and 22 WM by L-NMA and L-
NNA, respectively. To determine the ability of L-Arg to over-
come the inhibitory e¡ect of L-NNA, variable amounts of L-
Arg and a ¢xed amount of L-NNA were incubated with
BAEC for 60 min at 37‡C prior to inducing NO synthesis
with Ap4A. L-Arg, as expected, e¡ectively reverses the L-
NNA inhibition of NO release (Fig. 4B). In addition, L-
NNA inhibited basal release of NO and L-Arg overcame
this inhibition (data not shown).
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Fig. 3. Time course of [32P]-Ap4A and [K-32P]-ATP hydrolysis by
BAEC. 2U105 BAEC were seeded in 35 mm gelatin-coated petri
dishes, grown and prepared as described in Section 2. These cells
were incubated at room temperature with 6 WM Ap4A (1U106
cpms/pmole) (F) or with 6 WM ATP (1U106 cpms/pmole) (E) in a
¢nal volume of 0.1 ml of Krebs-Henseleit bu¡er for the times indi-
cated. After the incubations 2 Wl aliquots, along with standards,
were spotted on TLC plates. The nucleotides were separated as de-
scribed in Section 2. The relative percentage was calculated from
densitometer tracings of the autoradiographs as described in Section
2. The results are expressed as averages of three di¡erent experi-
ments. Error bars are shown as standard deviations.
Table 2
The role of Ca2 on the release of NO from BAEC
Sample nmoles/min/106 cells
Basal control 0.22 þ 0.020
Basal with no Ca2 plus 10 mm EGTA 0.01 þ 0.001
Ap4A control 0.87 þ 0.043
Ap4A with no Ca2 plus 10 mM EGTA 0.03 þ 0.002
2U105 BAEC were seeded in 35 mm gelatin-coated petri dishes,
grown and prepared as described in Section 2. In the Ap4A experi-
ments the concentration of Ap4A used was 6 WM. NO release was
recorded and analyzed as described in Section 2. Data are averages of
four di¡erent experiments and reported as standard deviations.
Fig. 2. Time course of adenine nucleotides induced NO release from
BAEC. 2U105 BAEC were seeded in 35 mm gelatin-coated petri
dishes, grown and prepared as described in Section 2. A: Six WM
Ap4A (F), 6 WM Ap2A (E), 6 WM ATP (b) and no nucleotide (a)
were incubated with cells for the various times indicated and the
NO released was recorded and analyzed as described in Section 2.
B: Six WM Ap4A (F), 6 WM Ap6A (E), 6 WM Ap5A (O), 6 WM
Ap3A (b) and no nucleotide (a) were incubated with cells for the
various times indicated and the NO released was recorded and ana-
lyzed as described in Section 2. Data are averages of four di¡erent
experiments. Error bars are shown as standard deviations.
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3.5. The role of Ca2+ on the release of NO from BAEC
Since eNOS has a strong requirement for calmodulin and
Ca2 [28], the role of Ca2 Ap4A induced release of NO was
examined. The addition of 10 mM EGTA to Ca2 free Krebs-
Henseleit bu¡er inhibits both basal and Ap4A stimulated re-
lease of NO (Table 2). Ap4A induced release of NO in Ca2
free bu¡er is 2.9% of the control while basal release is 4.5% of
the control. These data are consistent with Ap4A inducing
NO release through the eNOS pathway.
4. Discussion
Endothelial cells are believed to mediate the vasodilatory
actions of a variety of substances including adenine mononu-
cleotides. The biological e¡ects of adenine mononucleotides,
but not the adenine dinucleotides, on endothelial cells have
been well characterized. The major e¡ect of adenine nucleo-
tides on the endothelium is the stimulation of the synthesis
and release of prostacyclin and NO [28^35]. Work presented
in this communication demonstrates for the ¢rst time that
Ap4A and Ap2A induce the release of NO from endothelial
cells.
Even though eNOS was initially termed a ‘constitutive’ en-
zyme, we determined the amount of basal and Ap4A induced
NO release at di¡erent days of cell growth. Both basal and
Ap4A induced release of NO was at least 3-fold greater in
growing compared to growth-arrested cells (Fig. 1). These
data are consistent with other investigators who have demon-
strated that basal and Ca2 ionophore A-23187 induced re-
lease of NO was greater in growing BAEC [25]. Furthermore
Western and Northern blot analyses revealed 3- and 6-fold
increases in NO synthase protein and mRNA, respectively,
in growing compared with growth-arrested cells [25].
Of the various adenylated dinucleotides tested only Ap4A
and Ap2A induce the release of NO from BAEC (Fig. 2 and
Table 1). These data are consistent with data from the infu-
sion of Ap4A and Ap2A into animal models which demon-
strated that these two adenylated dinucleotides induce vaso-
dilation [1,2,14,18]. While Ap4A is a naturally occurring
adenylated dinucleotide, Ap2A has never been found in living
systems. Ap3A did not induce BAEC to release NO above
basal levels (Fig. 2B and Table 1), however other investigators
have reported that the infusion of Ap4A and Ap3A into seg-
ments of rabbit mesenteric arteries causes vasodilation [36].
These investigators also presented evidence which suggested
that Ap4A induces an endothelium dependent dilation while
Ap3A elicits a dilator response through a direct e¡ect on
vascular smooth muscle [36]. Neither Ap5A nor Ap6A induce
the release of NO above basal levels (Fig. 2B and Table 1).
Other investigators have demonstrated that Ap5A and Ap6A
induce vasoconstriction [7,14].
Under our experimental conditions Ap4A induces the re-
lease of about 53% more NO than ATP (Fig. 2A and Table
1). Since endothelial cells contain ecto-enzymes that hydrolyze
ATP and Ap4A [37], it was necessary to determine under our
experimental conditions whether the e¡ect of these two
nucleotides on NO release was due in part to their degradative
products. ATP hydrolysis by BAEC was signi¢cantly greater
than Ap4A hydrolysis (Fig. 3). In fact, after 60 min essentially
all of the ATP was hydrolyzed while only 10% of Ap4A was
hydrolyzed. Other investigators have also demonstrated
that Ap4A survives signi¢cantly longer on the endothelium
than ATP [37]. Furthermore, the half-life of Ap4A in whole
blood is also longer than the half-life of ATP [11]. Thus,
compared to ATP, Ap4A appears to be well suited for a
role as an extracellular modulator of NO release from the
endothelium.
Previous studies have shown that eNOS generates NO from
the terminal guanidino nitrogen of L-Arg yielding citrulline as
a by-product [26,27]. We demonstrate that Ap4A induced re-
lease of NO is inhibited by two competitive inhibitors of
eNOS, L-NMA and L-NNA. In addition, L-Arg reversed
this inhibition. Biochemical characterization of NOS has re-
vealed a strong requirement for calmodulin and Ca2 [38]. We
have demonstrated that the removal of Ca2 by 10 mM
EGTA inhibits greater than 97% of the Ap4A induced NO
release (Table 2). These data are consistent with Ap4A induc-
ing eNOS to synthesize NO. At the present time we do not
know whether Ap4A induces Ca2 mobilization in BAEC
through the internal sink or externally through Ca2 in£ux
through receptor operated Ca2 channels or through Ca2
transport mechanisms. Studies are in progress directed at de-
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Fig. 4. E¡ect of L-Arg analogs on Ap4A induced release of NO
from BAEC. A: 2U105 BAEC were seeded in 35 mm gelatin-coated
petri dishes, grown and prepared as described in Section 2. Cells
were incubated for 60 min at 37‡C with varying concentrations of
L-NMA (E) or L-NNA (F) prior to adding 6 WM Ap4A. NO re-
lease was recorded and analyzed as described in Section 2. B:
2U105 BAEC were seeded in 35 mm gelatin-coated petri dishes,
grown and prepared as described in Section 2. Cells were incubated
for 60 min at 37‡C with 100 WM L-NNA and varying concentra-
tions of L-Arg prior to adding 6 WM Ap4A. NO release was re-
corded and analyzed as described in Section 2. Data are averages of
four di¡erent experiments. Error bars are shown as standard devia-
tions.
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termining the mechanism of Ap4A induced Ca2 mobilization
in endothelial cells.
Our studies along with others on the infusion of Ap4A into
animal models or isolated arteries demonstrate that Ap4A is a
vasodilator. Ap4A has a longer stability in vivo and induces
the release of a greater amount of NO from endothelial cells
than ATP. These data clearly support the notion that Ap4A is
a physiologically important vasoregulator.
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